The UK-based Financial Times published an article yesterday reporting that Temasek Holdings is stepping up pressure on Standard Chartered’s CEO as losses continue to mount for Temasek in its investments in Standard Chartered (‘Temasek steps up pressure over Standard Chartered turnaround‘, 21 Jan).

It reported that Temasek, which is currently the largest shareholder of Standard Chartered at about 16%, has grown “frustrated” with Standard Chartered’s chief executive Bill Winters’ turnaround plan. Apparently, the plan is not working well and share price of Standard Chartered has plummeted considerably.

The bank’s share price has fallen almost 40 per cent since Winters took over in June 2015. It now hovers around £6 currently compared with a price of £15.24 when Temasek first bought in during 2006. That is to say, Temasek could be sitting on losses as high as 60%, losing £billions in paper losses.

StanChart CEO doing his best for the bank he inherited

Winters inherited a bank saddled with billions of dollars of bad loans and regulatory penalties caused by the reckless expansion across emerging markets overseen by his predecessor Peter Sands.

As such, Winters has spent much of his time overhauling compliance and risk management systems while drumming home the importance of culture to its 86,000 employees in 60 countries.

“I’m afraid Standard Chartered is pretty much as before. Bill is doing all the right things, but it was in a bad mess and current economic weakening doesn’t help,” said Hugh Young, head of Asia Pacific at Aberdeen Standard Investments, which holds about 5 per cent in the bank.

“Although it’s smaller than the supertanker of HSBC, it doesn’t have the engine of Hong Kong that HSBC does, so it’s taking every bit as long, if not longer, to reform. But we’re still very supportive,” said Young.

But Temasek is less supportive than Aberdeen Standard Investments. It has asked for more frequent and detailed briefings from Standard Chartered and started floating the idea of taking a board seat in the bank. Temasek rarely gets involved in the day-to-day running of its portfolio companies. However, its interest to get involved in Standard Chartered shows that it is desperately trying to help revive the share price of the bank.

Temasek has asked the bank’s executives why, even after three years of restructuring, they are unable to generate close to the double-digit return on equity (ROE) enjoyed by Asian rivals such as Singapore’s DBS Group.

A source told FT that Temasek is also concerned about the bench of internal candidates that could replace Winters. It said that Temasek would prefer someone such as DBS CEO Piyush Gupta, who has a proven record in turning round DBS.

Temasek declined to comment for the article, FT said.

 

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

SingHealth quietly blocks access to webpage featuring its “International Medical Service”

After news surfaced yesterday (30 Sep) that Ministry of Health (MOH) had…

中国抗疫前线首位医院院长 感染武汉冠状病毒离世

中央电视台报道,湖北省武昌医院院长刘智明感染武汉冠状病毒,经全力抢救后,于今早10点30分去世,享年50岁。这也是中国抗疫至今,首位前线牺牲的医院院长。 在周一晚间,微博上认证为湖北卫健委宣教中心党委书记、主任身分帐号率先发布刘智明去世的消息,并称他是“第一个牺牲的院长”。然而,梨视频之后发布刘智明的妻子影片表示,刘智明目前仍在抢救中,但病情严重,已经上了ECMO(叶克膜)。 据公开资料显示,刘智明为湖北十堰人,于1969年出生,1991年毕业于武汉大学医学院,擅长颅脑外伤,颅内肿瘤,脑血管病及椎管内病的诊断和治疗,特别擅长神经外科疾病手术治疗。 刘智明现为湖北中医药大学和江汉大学硕士研究生导师,2013年曾被武昌区委区政府授予“武昌英才”荣誉称号,2014年获“武汉市人民政府博士资助”人选,2015年获武汉市“十百千人才工程”人选。 本月17日晚,微博认证为湖北省卫健委宣教中心党委书记、主任的账户@全科健康发布信息称,“刘智明先生于当晚,走了”,并称他是“第一个牺牲的院长”。 但随后界面新闻也传出,从武昌医院院长刘智明的家人和一名武昌医院工作人员处分别获悉,刘智明正在同济医院重症监护室接受抢救,“专家还在看。” 据央视新闻报道,武昌医院2014年被湖北省卫计委评估为三级综合医院,现有员工966人,是这次新冠肺炎武汉市首批定点医院之一。制服该院59岁护士柳帆因感染武汉冠状病毒医治无效去世。

WP town council to go back to court – again

The Workers’ Party-run town council, Aljunied-Hougang Town Council (AHTC), is seeking the…

Netizens call out MOM to take "preemptive action" instead of just a "reactive action" on dormitories living condition

In view of the growing numbers of COVID-19 infections in the country,…